Thermo Fisher Cuts Annual Profit Outlook Amid Estimated $400M Tariff Hit

Company Accelerates Domestic Production And Supply Chain Shifts To Absorb Rising Costs.

Thermo Fisher is aggressively managing its supply chain and cost base using its Practical Process Improvement (PPI) Business System. The company is also increasing investments in US-based manufacturing and R&D, with around $2bn allocated to bolster domestic operations.

tariffs and shipping containers
The company executives say these mitigation measures are already underway and will largely neutralize the financial hit by 2026. (Shutterstock)

More from Strategy

More from Medtech Insight